Soma Pharmacy Blognews

Ipsen, Debiopharm Launch Cancer Drug In France Ipsen and its partner, Debiopharm, have launched Decapeptyl LP 22.5mg, a sustained release drug for treatment of locally-advanced or metastatic hormone-dependent prostate cancer, in France. The company also plans to launch the drug in Germany and Portugal in due time.

Mintaka Foundation for Medical Research Receives £2.7m For HIV Research The Mintaka Foundation for Medical Research in Geneva has received fund of £2.7m from Wellcome Trust, London. The fund will be used to proceed an anti-HIV microbicide known as 5P12-RANTES, to clinical trials.

Progenics Pharmaceuticals to present preclinical data of multiplex PI3K inhibitors Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on a series of novel compounds that simultaneously blocked two critical pathways involved in the growth and survival of cancer cells.

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under [...]

TenX Biopharma acquires exclusive global rights to zanolimumab from Genmab TenX Biopharma, Inc. announced today it has signed a licensing agreement to acquire exclusive worldwide rights to develop and commercialize zanolimumab (HuMax-CD4®) from Genmab A/S.

Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics Alkermes, Inc. today announced that it has developed a novel, proprietary LinkeRx™ technology platform to enable the creation of injectable extended-release versions of antipsychotics and other central nervous system (CNS) therapies.

"Knowledge deficit" about methadone responsible for resulting deaths In a unique and comprehensive literature review of poisoning deaths involving opioids from 1999 — 2009, the deaths involving methadone were found to be disproportionately high. Methadone represented less than five percent of all opioid prescriptions but is responsible for a third of the deaths. After four [...]

Expert available to discuss Lancet’s retraction of paper on autism study Rae Sonnenmeier, clinical associate professor of communication sciences and disorders at the University of New Hampshire and staff member at UNH’s Institute on Disability, is available to discuss the announcement yesterday (Feb. 2, 2010) by the medical journal The Lancet regarding the retraction of [...]

Phase Forward to participate in DIA Workshop and Clinical Trial Supply event Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, will participate in two industry events this month: The 13th Annual DIA Workshop in Japan for Clinical Data Management (Booths 4 and 5) and VIB Pharma’s 11th Annual [...]

February issue of Chest releases latest medical news Inhaled corticosteroids (ICS) are widely used for the treatment of chronic obstructive pulmonary disease (COPD). However, new research suggests that ICS may only provide a modest benefit in reducing exacerbations in patients with COPD.